Antihemophilic Factor: Separation of an Active Fragment Following Dissociation by Salts or Detergents

Summary

Dissociation of canine antihemophilic factor (factor VIII, molecular weight >2 × 10⁶) by salts and detergents was studied with the use of agarose gel chromatography. The dissociated fragments retained antihemophilic factor activity. Partial dissociation occurred in 1 M or 2 M KCl, 1 M KBr, 0.25% sodium desoxycholate and 0.1% Triton X-100, but essentially no dissociation was observed in 3 M KC1. A high degree of dissociation occurred in 0.25 M CaCl₂. Removal of Ca²⁺ before chromatographic fractionation of the preparation resulted in complete reversal of the dissociation. However, upon separation of an active, dissociated fraction from the very high molecular weight components by gel chromatography in 0.25 M CaCl₂, followed by removal of Ca²⁺ from the fraction, no tendency toward reaggregation was seen. The apparent molecular weight of the dissociated fragment, determined by gel chromatography, is about 25,000. It is proposed that antihemophilic factor activity is associated with a molecule, of relatively low molecular weight, which in plasma or partially purified fractions is bound by electrostatic and hydrophobic bonds to a high molecular weight carrier. The activities of both dissociated and undissociated preparations were neutralized by an antibody to human antihemophilic factor. In contrast to the behavior of undissociated antihemophilic factor, the activity of the dissociated preparation was not affected by incubation with a dilute, highly purified thrombin preparation.

This investigation was supported by Research Grant HE06350 from the National Heart and Lung Institute.

^* Supported in part by Training Grants 5T01-GM00404 and GM-92 from the National Institute of General Medical Sciences.

^** Correspondence should be addressed to the Department of Pathology.

• References

• 1 Ackers G. K. Analytical gel chromatography of proteins. Advanc. Prot. Chem 24: 343 1970;
• 2 Barrow E. M, Graham J. B. Kidney antihemophilic factor. Partial purification and some properties. Biochemistry 07: 3917 1968;
• 3 Barrow E. M, Graham J. B. Factor VIII (AHF) activity of small molecular size produced by succinylating plasma. Amer. J. Physiol. 1972 (In press.)
• 4 Bidwell E, Dike G. R. W, Denson K. W. E. Experiments with factor VIII separated from fibrinogen by electrophoresis in a free buffer film. Brit. J. Haemat 12: 583 1966;
• 5 Biggs R, Macfarlane R. G, Denson K. W. E, Ash B. J. Thrombin and the interaction of factors VIII and IX. Brit. J. Haemat 11: 276 1965;
• 6 Cox A. C, Hanahan D. J. The isolation of undegraded bovine prothrombin and its partial characterization. Biochim. biophys. Acta (Amst) 207: 49 1970;
• 7 Feinstein D. I, Rapaport S. I, Chong M. N. Y. Immunologic characterization of 12 factor VIII inhibitors. Blood. 34. 85 1969a
• 8 Feinstein D, Chong M. N. Y, Kasper C. K, Rapaport S. I. Hemophilia A: polymorphism detectable by a factor VIII antibody. Science 163: 1071 1969b
• 9 Friedman R. Characterization of sugar components of proteins. Biochem. J 44: 117 1949;
• 10 Hershgold E. J, Davison A. M, Janszen M. E. Isolation and some chemical properties of human factor VIII (antihemophilic factor). J. Lab. Clin. Med 77: 185 1971;
• 11 Hershgold E. J, Sprawls S. Molecular properties of purified human, bovine and porcine antihemophilic globulins (AHG). Fed. Proc 25: 317 1966;
• 12 Langdeil R. D, Wagner R. H, Brinkhous K. M. Effect of antihemophilic factor on one-stage clotting tests. J. Lab. clin. Med 41: 637 1953;
• 13 Lowry O. H, Roseborough N. J, Farr A. L, Randall R. J. Protein measurement with the Folin phenol reagent. J. biol. Chem 193: 265 1951;
• 14 Lundblad R. L. A rapid method for the purification of bovine thrombin and the inhibition of the purified enzyme with phenylmethylsulfonyl fluoride. Biochemistry 10: 2501 1971;
• 15 Margolis J. The kaolin clotting time. A rapid one-stage method for diagnosis of coagulation defects. J. clin. Path 11: 406 1958;
• 16 Owen W. G, Wagner R. H. Antihemophilic factor. A new method for purification. Thrombosis Research 01: 71 1972;
• 17 Özge-Anwar A. H, Connell G. E, Mustard J. F. The activation of factor VIII by thrombin. Blood 26: 500 1965;
• 18 Rapaport S. I, Schiffman S, Patch M. J, Ames S. B. The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrom- binase activity. Blood 21: 221 1963;
• 19 Ratnoff O. D, Kass L, Lang P. D. Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma. J. clin. Invest 48: 957 1969;
• 20 Schmer D, Davie E. W. Preparation and properties of bovine antihemophilic factor. Amer. Chem. Soc., Div. Biol. Chem. 158th Nat. Meeting, Abstract No. 188 1969
• 21 Schrier E. E, Schrier E. B. The salting out behavior of amides and its relation to the dénaturation of proteins by salts. J. Phys. Chem 71: 1851 1967;
• 22 Seegers W. H. Preparation, purification and assay of thrombin. In: Blood Coagulation, Haemorrhage and Thrombosis. Tocantins L. M, Kazal A. L. eds. Grune and Stratton; New York: 1964: 184.
• 23 SØrenson M, Haugaard G. The application of the orcinol reaction to the estimation of the nature and amount of carbohydrate groups in proteins. C.R. Trav. Lab. Carls 19: 1 1933;
• 24 Thelin G. M, Wagner R. H. Sedimentation of plasma antihemophilic factor. Arch. Biochem 95: 70 1961;
• 25 Thompson A. R, Davie E. W. Affinity chromatography of thrombin. Biochim. biophys. Acta (Amst) 250: 210 1971;
• 26 Weiss H. J, Kochwa S. Molecular forms of antihemophilic globulin in plasma, cryoprecipitate and after thrombin activation. Brit. J. Haemat 18: 89 1970;